{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T17:06:21Z","timestamp":1781888781129,"version":"3.54.5"},"reference-count":28,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1016\/j.ophtha.2006.05.022","type":"journal-article","created":{"date-parts":[[2006,8,2]],"date-time":"2006-08-02T17:43:06Z","timestamp":1154540586000},"page":"1785-1790","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Efficacy of Topical Cyclosporine 0.05% for Prevention of Cornea Transplant Rejection Episodes"],"prefix":"10.1016","volume":"113","author":[{"given":"Marianne O.","family":"Price","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Francis W.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2006.05.022_bib1","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1001\/archopht.121.8.1087","article-title":"Risk factors for various causes of failure in initial corneal grafts","volume":"121","author":"Price","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.05.022_bib2","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3928\/1081-597X-19960101-24","article-title":"Risk factors for corneal graft failure","volume":"12","author":"Price","year":"1996","journal-title":"J Refract Surg"},{"key":"10.1016\/j.ophtha.2006.05.022_bib3","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/S0161-6420(03)00463-9","article-title":"Long-term graft survival after penetrating keratoplasty","volume":"110","author":"Thompson","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2006.05.022_bib4","first-page":"120","volume":"Vol. 7","year":"2004"},{"key":"10.1016\/j.ophtha.2006.05.022_bib5","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0161-6420(91)32292-9","article-title":"Graft survival in four common groups of patients undergoing penetrating keratoplasty","volume":"98","author":"Price","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2006.05.022_bib6","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s00347-003-0953-5","article-title":"Current practice of immune prophylaxis and therapy in perforating keratoplasty: a survey of members of the Cornea Section of the German Ophthalmological Society [in German]","volume":"100","author":"Bertelmann","year":"2003","journal-title":"Ophthalmologe"},{"key":"10.1016\/j.ophtha.2006.05.022_bib7","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0886-3350(00)00364-3","article-title":"Effect of topical anti-inflammatory drugs on corneal and limbal wound healing","volume":"26","author":"Barba","year":"2000","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.ophtha.2006.05.022_bib8","first-page":"108","article-title":"Ocular toxicity of corticosteroids","volume":"Vol. 11","author":"Leibowitz","year":"1979"},{"key":"10.1016\/j.ophtha.2006.05.022_bib9","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/archopht.1963.00960050484010","article-title":"Effect of corticosteroids on intraocular pressure and fluid dynamics. I. The effect of dexamethasone in the normal eye","volume":"70","author":"Armaly","year":"1963","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.05.022_bib10","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1001\/archopht.1963.00960050494011","article-title":"Effect of corticosteroids on intraocular pressure and fluid dynamics. II. The effect of dexamethasone in the glaucomatous eye","volume":"70","author":"Armaly","year":"1963","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.05.022_bib11","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0002-9394(88)90595-8","article-title":"Intraocular pressure response to topical dexamethasone as a predictor for the development of primary open-angle glaucoma","volume":"106","author":"Lewis","year":"1988","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.05.022_bib12","first-page":"198","article-title":"Intraocular pressure response to topical corticosteroids","volume":"4","author":"Becker","year":"1965","journal-title":"Invest Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.05.022_bib13","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/S0161-6420(91)32136-5","article-title":"Progression of visual acuity after penetrating keratoplasty","volume":"98","author":"Price","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2006.05.022_bib14","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.4049\/jimmunol.129.5.1865","article-title":"Analysis of cloned T cell function. I. Dissection of cloned T cell proliferative responses using cyclosporin A","volume":"129","author":"Orosz","year":"1982","journal-title":"J Immunol"},{"key":"10.1016\/j.ophtha.2006.05.022_bib15","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.4049\/jimmunol.138.4.1115","article-title":"The cyclosporins inhibit lymphocyte activation at more than one site","volume":"138","author":"Gelfand","year":"1987","journal-title":"J Immunol"},{"key":"10.1016\/j.ophtha.2006.05.022_bib16","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/01.ico.0000138841.44926.f8","article-title":"Opinions on risk factors and management of corneal graft rejection in the United Kingdom","volume":"24","author":"Koay","year":"2005","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2006.05.022_bib17","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/S0161-6420(02)01081-3","article-title":"Long-term outcomes of keratolimbal allograft for the treatment of severe ocular surface disorders","volume":"109","author":"Ilari","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2006.05.022_bib18","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.ophtha.2003.07.013","article-title":"Long-term results of allogeneic penetrating limbo-keratoplasty in total limbal stem cell deficiency","volume":"111","author":"Reinhard","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2006.05.022_bib19","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/sj.eye.6700640","article-title":"Limbal autograft and allograft transplantations in patients with corneal burns","volume":"18","author":"Ozdemir","year":"2004","journal-title":"Eye"},{"key":"10.1016\/j.ophtha.2006.05.022_bib20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/01.ICL.0000062460.03555.32","article-title":"Topical cyclosporine in pediatric keratoplasty","volume":"29","author":"Cosar","year":"2003","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.ophtha.2006.05.022_bib21","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/00003226-199811000-00002","article-title":"The pathology of dry eye: the interaction between the ocular surface and lacrimal glands","volume":"17","author":"Stern","year":"1998","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2006.05.022_bib22","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0161-6420(00)00035-X","article-title":"Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial","volume":"107","author":"Stevenson","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2006.05.022_bib23","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1517\/14656566.5.10.2099","article-title":"Topical 0.05% cyclosporin in the treatment of dry eye","volume":"5","author":"Perry","year":"2004","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.ophtha.2006.05.022_bib24","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0161-6420(99)00176-1","article-title":"Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease","volume":"107","author":"Sall","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2006.05.022_bib25","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0939-6411(03)00138-3","article-title":"Cyclosporine A delivery to the eye: a pharmaceutical challenge","volume":"56","author":"Lallemand","year":"2003","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.ophtha.2006.05.022_bib26","first-page":"159","article-title":"Topical cyclosporine A in the management of postkeratoplasty glaucoma and corticosteroid-induced ocular hypertension (CIOH) and the penetration of topical 0.5% cyclosporine A into the cornea and anterior chamber","volume":"24","author":"Perry","year":"1998","journal-title":"CLAO J"},{"key":"10.1016\/j.ophtha.2006.05.022_bib27","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1097\/01.ico.0000159730.45177.cd","article-title":"Outcomes of penetrating keratoplasty in keratoconus","volume":"24","author":"Javadi","year":"2005","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2006.05.022_bib28","series-title":"Corneal Graft Failure","first-page":"151","article-title":"The allograft rejection reaction: the leading cause of late failure of clinical corneal grafts","author":"Khodadoust","year":"1973"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642006006890?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642006006890?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:50:45Z","timestamp":1758981045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642006006890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["S0161642006006890"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2006.05.022","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of Topical Cyclosporine 0.05% for Prevention of Cornea Transplant Rejection Episodes","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2006.05.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}